AXIS reported total gross premiums of $9 billion for the year, with $2.6 billion generated from new business. The Insurance segment produced $6.6 billion in premiums, a 7.7% increase, while ...

Here is how the Barron’s Roundtable members’ picks performed. Find investment ideas for your portfolio with the latest stock picks from Barron’s below. These picks are the product of the ...

Akero Therapeutics (AKRO) stock was upgraded by Bank of America based on Phase 2 data the company shared for its liver disorder drug, efruxifermin. Read more here.